Gene · 11309
Papers1,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters? | Int J Mol Sci | 2024 | 39596105 | PubTator, text mining | PubMed |
| M2ara: unraveling metabolomic drug responses in whole-cell MALDI mass spectrometry bioassays. | Bioinformatics | 2024 | 39558590 | PubTator, text mining | PubMed |
| Percutaneous Penetration and Dermal Exposure Risk Assessment of UV Absorbents in Sunscreens and Isolation Cosmetics. | Environ Health (Wash) | 2024 | 39474286 | PubTator, text mining | PubMed |
| Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy. | Pharmaceutics | 2024 | 39458619 | PubTator, text mining | PubMed |
| Thai pharmacogenomics database -2 (TPGxD-2) sequel to TPGxD-1, analyzing genetic variants in 26 non-VIPGx genes within the Thai population. | Clin Transl Sci | 2024 | 39449569 | PubTator, text mining | PubMed |
Interaction of myricetin, ampelopsin (dihydromyricetin), and their sulfate metabolites with serum albumin, cytochrome P450 (CYP2C9, 2C19, and 3A4) enzymes, and organic anion-transporting polypeptides (OATP1B1 and OATP2B1). | Pharmacol Res Perspect | 2024 | 39344282 | PubTator, text mining | PubMed |
| 18β-Glycyrrhetinic acid synergizes with enzalutamide to counteract castration-resistant prostate cancer by inhibiting OATP2B1 uptake of dehydroepiandrosterone sulfate. | Eur J Pharmacol | 2024 | 39277096 | PubTator, text mining | PubMed |
| Lack of effects of polystyrene micro- and nanoplastics on activity and expression of human drug transporters. | Environ Toxicol Pharmacol | 2024 | 39260711 | PubTator, text mining | PubMed |
| The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes. | Front Pharmacol | 2024 | 39170705 | PubTator, text mining | PubMed |
| Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities. | Gut Microbes | 2024 | 39150897 | PubTator, text mining | PubMed |
| Dysregulation of Human Hepatic Drug Transporters by Proinflammatory Cytokines. | J Pharmacol Exp Ther | 2024 | 39103232 | PubTator, text mining | PubMed |
| Impact of OATP2B1 on Pharmacokinetics of Atorvastatin Investigated in rSlco2b1-Knockout and SLCO2B1-Knockin Rats. | Drug Metab Dispos | 2024 | 39038952 | PubTator, text mining | PubMed |
| Preincubation-dependent inhibition of organic anion transporting polypeptide 2B1. | Eur J Pharm Sci | 2024 | 39019347 | PubTator, text mining | PubMed |
| Downregulation of OATP2B1 by proinflammatory cytokines leads to 5-ASA hyposensitivity in Ulcerative colitis. | Chem Biol Interact | 2024 | 38844255 | PubTator, text mining | PubMed |
| Evaluation of the Clinical Drug-Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach. | Clin Pharmacol Drug Dev | 2024 | 38752475 | PubTator, text mining | PubMed |
| A face-to-face comparison of the BBB cell models hCMEC/D3 and hBMEC for their applicability to adenoviral expression of transporters. | J Neurochem | 2024 | 38735840 | PubTator, text mining | PubMed |
| Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins. | CPT Pharmacometrics Syst Pharmacol | 2024 | 38576225 | PubTator, text mining | PubMed |
| The Active Glucuronide Metabolite of the Brain Protectant IMM-H004 with Poor Blood-Brain Barrier Permeability Demonstrates a High Partition in the Rat Brain via Multiple Mechanisms. | Pharmaceutics | 2024 | 38543224 | PubTator, text mining | PubMed |
| Conversion of Olmesartan to Olmesartan Medoxomil, A Prodrug that Improves Intestinal Absorption, Confers Substrate Recognition by OATP2B1. | Pharm Res | 2024 | 38485855 | PubTator, text mining | PubMed |
The Role of CYPs and Transporters in the Biotransformation and Transport of the Anti-hepatitis C Antiviral Agents Asunaprevir, Daclatasvir, and Beclabuvir: Impact of Liver Disease, Race and Drug-drug Interactions on Safety and Efficacy. | Curr Drug Metab | 2024 | 38441017 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11309/papers?page=4